Research Project

Project Title:	Study of Sparsentan in Patients With Primary Focal Segmental Glomerulosclerosis (FSGS) (DUPLEX)
Project Type:	Clinical Trial, Enrolment ongoing
Disease group(s):	Hereditary glomerulopathies
Project Summary:	To determine the long-term nephroprotective potential of treatment with sparsentan as compared to an angiotensin receptor blocker in patients with primary and genetic focal segmental glomerulosclerosis (FSGS).
Lead principal investigator(s):	Giovanni Montini, Milan
Project Period:	04/2017 - 09/2050
Project web page:	https://clinicaltrials.gov/study/NCT03493685#study-overview
ClinicalTrials.gov:	NCT03493685